CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 884546
SAN FRANCISCO, CA
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,674,073
+$10,041,549 QoQ
Shares Held
365,963
+19.8% QoQ
Ownership
0.654%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 269 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. DNTH ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in DNTH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,674,073 | 365,963 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,632,524 | 305,440 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,335,962 | 250,812 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,596,871 | 193,059 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,061,151 | 164,313 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,049,370 | 168,102 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,641,057 | 167,021 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,543,136 | 165,929 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,774,513 | 68,567 | Shares | Sole | 2024-08-12 | |
| 2023-06-30 MGTA | — | 27,369 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 MGTA | — | 27,369 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 MGTA | — | 27,369 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 MGTA | — | 27,369 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 MGTA | — | 89,145 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 MGTA | — | 83,056 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 MGTA | — | 83,056 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 MGTA | — | 74,777 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 MGTA | — | 54,653 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 MGTA | — | 50,826 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 MGTA | — | 50,826 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 MGTA | — | 44,439 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 MGTA | — | 48,467 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||